Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting Molecular Signaling Pathways and Cytokine Responses to Modulate c-MYC in Acute Myeloid Leukemia

Frontiers in Bioscience-Scholar(2024)10.31083/j.fbs1603015Source: DataRank Database

Targeting Molecular Signaling Pathways and Cytokine Responses to Modulate c-MYC in Acute Myeloid Leukemia is a research paper published in Frontiers in Bioscience-Scholar (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.13)OA: goldTopics (41)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Harry May,Min H. Kang ORCID,Kyle J. Gu ORCID

Live enrichment

PubMed:39344393 OpenAlex:https://openalex.org/W4402997486

National Cancer Institute, NIH

Grant: R01 CA168699

Cancer Prevention and Research Institute of Texas

Grant: RP170470

Cancer Prevention and Research Institute of Texas

Grant: RP130547

National Institutes of Health

Grant: 1R01CA168699-01A1

Pharmacokinetics and pharmacogenomics for 13-cis retinoic acid in neuroblastoma

FWCI

1.13

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://storage.imrpress.com/IMR/FBS24918/application/1945-0524-16-3-015.pdf

GOLDhttps://doi.org/10.31083/j.fbs1603015

publisherhttps://storage.imrpress.com/IMR/FBS24918/application/1945-0524-16-3-015.pdf

publisherhttps://www.imrpress.com/journal/FBS/16/3/10.31083/j.fbs1603015

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39344393

Fields of Study

Protein Degradation and InhibitorsAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsMedicine0301 basic medicine03 medical and health sciences

MeSH Terms

HumansSignal TransductionLeukemia, Myeloid, AcuteCytokinesProto-Oncogene Proteins c-mycMolecular Targeted Therapy

Keywords

Cancer researchMyeloid leukemiaPI3K/AKT/mTOR pathwayProtein kinase BSignal transductionTargeted therapyMedicineLeukemiaPIM1Tyrosine kinaseBiologyImmunologyCancerPhosphorylationCell biologyInternal medicineCytokineSignaling pathwayMYCAcute myelogenous leukemiaQH301-705.5QD415-436BiochemistryProto-Oncogene Proteins c-mycLeukemia, Myeloid, AcuteHumansCytokinesMolecular Targeted TherapyBiology (General)

Sustainable Development Goals

SDG 0: Good health and well-being